Custom service
CPP Modification and Labeling
Label and modify cpps for tracking and functional studies
The service is built around fluorescent and radiolabel CPP tagging. Depending on the molecule we may move to stability-enhancing modifications or quenched (cargo-activated) designs to improve stability, loading or yield, and every batch is released with labeled CPP with label-ratio and uptake QC.
Because CPP Modification and Labeling projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Tracking CPP biodistribution in vitro
Quenched uptake-reporting constructs
Radiolabeled CPPs for human use
Cargo that must remain endosome-free without an escape strategy
CPP release includes chemical QC plus a functional dataset: uptake kinetics in the agreed cell line, endosomal-escape evidence where relevant, and viability across the working concentration range.
Service Highlights
- Fluorescent and radiolabel CPP tagging as the default route, with stability-enhancing modifications held as a proven fallback
- Quenched (cargo-activated) designs worked into the design where the application requires it
- Uptake is quantified by flow cytometry and confocal imaging together, so surface-bound signal is distinguished from true internalization
- Analytical confirmation of every intermediate before the final release
- Cytotoxicity is measured alongside uptake, because an aggressive CPP is often a toxic one
- Labeled CPP with label-ratio and uptake QC delivered with a complete conjugation or synthesis certificate
How the work runs
Cargo & motif matching
Cargo properties and target cell determine the CPP family; fluorescent and radiolabel CPP tagging is evaluated first.
Construct synthesis
CPP–cargo constructs are synthesized with stability-enhancing modifications for attachment geometry.
Uptake testing
Flow cytometry and confocal imaging quantify internalization against surface binding.
Toxicity profiling
Viability across the working range establishes the therapeutic window.
Optimization
Motif, linker and presentation are iterated until uptake-to-toxicity meets the target.
Release
Labeled CPP with label-ratio and uptake QC with uptake and viability documentation is released.
Specifications & timeline
- Turnaround
- 3–5 weeks
- Typical scale
- 1 – 50 mg CPP construct
- Chemistry options
- fluorescent and radiolabel CPP tagging; stability-enhancing modifications; quenched (cargo-activated) designs
- Deliverable
- Labeled CPP with label-ratio and uptake QC
- QC package
- HPLC purity, MS identity, uptake and viability data
- Shipping
- Blue ice, aliquoted, light-protected where labels require
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.